Global importance of new treatment strategies to efforts to control hepatitis B virus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Global importance of new treatment strategies to efforts to control hepatitis B virus

Published:2023-06-23 Issue:8 Volume:21 Page:847-862
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Forbes Carol¹,Lavoie Louis²,Satram Sacha³,Shen Ling⁴,Thanawala Vaidehi⁵,Arizpe Andre⁵,Terrault Norah⁶

Affiliation:

1. Evidence Synthesis, Evidera Ltd, London, UK

2. Evidence Synthesis, Evidera Inc, Montreal, Canada

3. Evidence, Value & Access, Vir Biotechology Inc, San Francisco, CA, USA

4. Biostatistics, Vir Biotechnology Inc, San Francisco, CA, USA

5. Clinical Research, Vir Biotechnology Inc, San Francisco, CA, USA

6. Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Funder

Vir Biotechnology

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2023.2225771

Reference74 articles.

1. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy

2. Hepatitis B virus burden in developing countries

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

4. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance

5. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The combination of Schisandrin C and Luteolin synergistically attenuates hepatitis B virus infection via repressing HBV replication and promoting cGAS-STING pathway activation in macrophages;Chinese Medicine;2024-03-18

2. Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China;International Journal of Clinical Pharmacy;2024-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3